p53 expression and proliferative activity predict survival in non-invasive thymomas

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 180-183

  Pich, Achille ^a,b   Chiarle, Roberto ^a   Chiusa, Luigi ^a   Ponti, Renata ^a   Geuna, Massimo ^a   Palestro, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMOMA; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEOLUS ORGANIZER REGION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SILVER STAINING; SURVIVAL ANALYSIS; THYMOMA; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030036970     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W     Document Type: Article

References (24)

1. BERNATZ, P.E., HARRISON, E.G. and CLAGETT, O., Thymoma: a clinicopathological study. J. Thorac. Cardiovasc. Surg., 42, 424-444 (1961).
2. BHARGAVA, V., THOR, A., DENG, G., LJUNG, B.M., MOORE, D.H. II, WALDMAN, F., BENZ, C., GOODSON, W. III, MAYALL, B., CHEW, K. and SMITH, H.S., The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod. Pathol., 7, 361-368 (1994).
3. BOSARI, S., RONCALLI, M., VIALE, G., BOSSI, P. and COGGI, G., p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J. Pathol., 169, 425-430 (1993).
4. DAVIES, S.E., MACARTNEY, J.C., CAMPLEJOHN, R.S., MORRIS, R.W., RING, N.P. and CORRIN, B., DNA flow cytometry of thymomas. Histopathology, 15, 77-83 (1989).
5. DERENZINI, M., PESSION, A. and TRERÈ, D., Quantity of nucleolar silver-stained proteins is related to proliferative activity in cancer cells. Lab Invest., 63, 137-140 (1990).
6. DERENZINI, M., SIRRI, V. and TRERÈ, D., Nucleolar organizer regions in tumor cells. Cancer J., 7, 71-77 (1994).
7. HAYASHI, Y., ISHII, N., OBAYASHI, C., JINNAI, K., HANIOKA, K., IMAI, Y. and ITOH, H., Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21. Virchows Arch., 426, 43-50 (1995).
8. HEDLEY, D.W., FRIEDLANDER, M.L., TAYLOR, I.W., RUGG, C.A. and MUSGROVE, E.A., Method for analysis of cellular DNA content of paraffin-embedded pathologic material using flow cytometry. J. Histochem. Cytochem., 31, 1333-1335 (1983).
9. ISOLA, J., VISAKORPI, T., HOLLI, K. and KALLIONIEMI, O.P., Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. nat. Cancer Inst., 84, 1109-1114 (1992).
10. JOENSUU, H. and KLEMI, P.J., Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Amer. J. clin. Pathol., 89, 35-40 (1988).
11. KERNS, B.M., JORDAN, P.A., MOORE, M.B.H., HUMPHREY, P.A., BERCHUCK, A., KOHLER, M.F., BAST, R.C., JR., IGLEBART, J.D. and MARKS, J.R., p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J. Histochem. Cytochem., 40, 1047-1051 (1992).
12. LEGG, M.A. and BRADY, W.J., Pathology and clinical behavior of thymomas. A survey of 51 cases. Cancer, 18, 1131-1144 (1965).
13. LEWIS, J.E., WICK, M.R., SCHEITHAUER, B.W., BERNATZ, P.E. and TAYLOR, W.F., Thymoma. A clinicopathologic review. Cancer, 60, 2727-2743 (1987).
14. MARTIN, H.M., FILIPE, M.I., MORRIS, R.W., LANE, D. and SILVESTRE, F., p53 expression and prognosis in gastric carcinoma. Int. J. Cancer, 50, 859-862 (1992).
15. MASAOKA, A., MONDEN, Y., NAKAHARA, K. and TANIOKA, T., Follow-up study of thymomas with special reference to their clinical stages. Cancer, 48, 2485-2492 (1981).
16. MÜLLER-HERMELINK, H.K., MARINO, M. and PALESTRO, G., Pathology of thymic epithelial tumors. In: H.K. Müller-Hermelink (ed.), The human thymus. Histophysiology and pathology. Current topics in pathology, vol. 75, pp. 207-268, Springer-Verlag, Berlin (1986).
17. PICH, A., CHIARLE, R., CHIUSA, L. and PALESTRO, G., Argyrophilic nucleolar organizer region counts predict survival in thymoma. Cancer, 74, 1568-1574 (1994).
18. PICH, A., CHIARLE, R., CHIUSA, L., PONTI, R., GEUNA, M., CASADIO, C., MAGGI, G. and PALESTRO, G., Long-term survival of thymoma patients by histologic pattern and proliferative activity. Amer. J. surg. Pathol., 19, 918-926 (1995).
19. POLLER, D.N., ROBERTS, E.C., BELL, J.A., ELSTON, C.W., BLAMEY, R.W. and ELLIS, I.O., p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum. Pathol., 24, 463-468 (1993).
20. QUINLAN, D.C., DAVIDSON, A.G., SUMMERS, C.L., WARDEN, H.E. and DOSHI, H.M., Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52, 4828-4831 (1992).
21. QUINTANILLA-MARTINEZ, L., WILKINS, E.W., CHOI, N., EFIRD, J., HUG. E. and HARRIS, N.L., Thymoma. Histologic subclassification is an independent prognostic factor. Cancer, 74, 606-617 (1994).
22. ROSAI, J. and LEVINE, G.D., Tumors of the thymus. In: I. Harlan and M.D. Ferminger (eds.), Atlas of tumor pathology (series 2, fascicle 13), pp. 1-221, Armed Forces Institute of Pathology, Washington DC (1976).
23. WALKER, R.A., DEARING, S.J., LANE, D.P. and VARLEY, J.M., Expression of p53 protein in infiltrating and in-situ breast carcinomas. J. Pathol., 165, 203-211 (1991).
24. ZHANG, Z.-F., KARPEH, M.S., LAUWERS, G.Y., MARRERO, A.M., POLLACK, D., CORDON-CARDO, C. and BEGO, C., Risk factors and p53 nuclear overexpression in early stage intestinal-type adenocarcinoma of the stomach. Cancer Detect. Prevent., 19, 156-164 (1995).